Pharmacodynamics: Comparison with the Standard
The synthetic opioid analgesic trimeperidine (Trimeperidinum) is an N-methylpiperidine derivative. In clinical pharmacology, this drug is traditionally compared to the reference opioid, morphine. In terms of analgesic potency, trimeperidine is 2–4 times weaker than morphine, but it possesses several clinically significant advantages.
Chief among these is its safety profile regarding the respiratory system. The drug causes significantly less depression of the respiratory center. This critically important property allows for its use in pediatric practice and obstetric analgesia. The pharmacokinetic parameters of trimeperidine are otherwise almost identical to those of morphine.
Effects on Smooth Muscle and Myometrium
A crucial pharmacodynamic difference between trimeperidine and morphine lies in its effect on smooth muscle structures. While classical opiates have a pronounced spasmogenic effect, trimeperidine exerts a spasmolytic action on the smooth muscle of the bronchial tree and ureters.
Regarding the intestines and biliary tract, a spasmogenic effect is present, but it is considerably less pronounced. The drug's effect on the female reproductive system is also noteworthy: trimeperidine specifically increases myometrial tone and stimulates its contractility.
Indications for Use
The specific pharmacological profile of trimeperidine dictates a wide range of clinical applications:
- Severe pain syndrome: relief of pain in severe trauma, oncological diseases, and the postoperative period.
- Obstetric analgesia: the drug is a preferred agent due to its safety for the fetal respiratory center and its ability to stimulate myometrial contractions.
- Relief of colic: used for renal and biliary colic because it not only relieves pain but also eliminates smooth muscle spasms via its spasmolytic component.
- Premedication: pharmacological preparation of patients for surgical interventions.
Adverse Reactions and Contraindications
Like all opioid analgesics, trimeperidine has several serious side effects. Its use may cause dyspeptic disorders (nausea, vomiting), general weakness, and dizziness. The most serious problem remains the risk of developing drug dependence — both psychological and physical.
An absolute contraindication to prescribing trimeperidine is the presence of respiratory failure in the patient, since, despite its milder action compared to morphine, the drug is still capable of depressing the respiratory center.